Patent Assignment
Reel/Frame 069094/0174
Assignment of Assignor's Interest
Recorded: 2024-10-01
Pages: 7
Assignee
TOLERO PHARMACEUTICALS, INC.
3900 N. TRAVERSE MOUNTAIN BLVD, LEHI, UTAH, 84043
Covered Property
(1)
Pim Kinase Inhibitors for Treatment of Myeloproliferative Neoplasms and Fibrosis Associated with Cancer
Application:
18/743,075 →
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger
Sep 18, 2024
From: SUMITOMO PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA AMERICA, INC.
Reel/Frame 068618/0375 →
Change of Name
Oct 1, 2024
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 069094/0181 →
Change of Name
Oct 1, 2024
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 069095/0329 →
Merger
Oct 1, 2024
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 068757/0850 →
Merger
Oct 1, 2024
From: SUMITOMO PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA AMERICA, INC.
Reel/Frame 068757/0957 →